Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.

Jiang F, Zhang Y, Peng F, Liu H, Ding K, Cao P, Liu X, Li L, Liu Z, Fu R

Open source

DOI: 10.1186/s12967-025-06319-3
Published: 2025 Mar 16
Container: Journal of translational medicine
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s12967-025-06319-3,
  title = {Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.},
  author = {Jiang F and Zhang Y and Peng F and Liu H and Ding K and Cao P and Liu X and Li L and Liu Z and Fu R},
  year = {2025},
  journal = {Journal of translational medicine},
  doi = {10.1186/s12967-025-06319-3},
  url = {https://doi.org/10.1186/s12967-025-06319-3}
}

RIS

TY  - JOUR
TI  - Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.
AU  - Jiang F
AU  - Zhang Y
AU  - Peng F
AU  - Liu H
AU  - Ding K
AU  - Cao P
AU  - Liu X
AU  - Li L
AU  - Liu Z
AU  - Fu R
PY  - 2025
JO  - Journal of translational medicine
DO  - 10.1186/s12967-025-06319-3
UR  - https://doi.org/10.1186/s12967-025-06319-3
ER  -

APA

F, J., Y, Z., F, P., H, L., K, D., P, C., X, L., L, L., Z, L., & R, F. (2025). Complement C3a promotes the formation of osteoclasts by inhibiting Sirt1 to activate the PI3K/PDK1/SGK3 pathway in patients with multiple myeloma.. Journal of translational medicine. https://doi.org/10.1186/s12967-025-06319-3

Source records

pubmed · retrieved 2026-09-26T22:42:50.165Z
europe-pmc · retrieved 2026-09-26T22:42:50.177Z
doaj · retrieved 2026-09-26T22:42:50.169Z